These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 10995902

  • 21. Intestinal transplantation at the University of Miami-five years of experience.
    Pinna AD, Weppler D, Nery J, Ruiz P, Kato T, Khan F, Levi D, Nishida S, De Faria W, Berho M, Tzakis AG.
    Transplant Proc; 2000 Sep; 32(6):1226-7. PubMed ID: 10995922
    [No Abstract] [Full Text] [Related]

  • 22. Is severe rejection an indication for retransplantation?
    Kato T, Berho M, Weppler D, Ruiz P, Pinna AD, Khan FA, Nery JR, Tzakis AG.
    Transplant Proc; 2000 Sep; 32(6):1201. PubMed ID: 10995907
    [No Abstract] [Full Text] [Related]

  • 23. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation.
    Hirose R, Roberts JP, Quan D, Osorio RW, Freise C, Ascher NL, Stock PG.
    Transplantation; 2000 Jan 27; 69(2):307-11. PubMed ID: 10670644
    [Abstract] [Full Text] [Related]

  • 24. New immunosuppressants in BMT/GVHD.
    Basara N, Günzelmann S, Willenbacher W, Fauser AA, Kiehl MG.
    Transplant Proc; 2001 May 27; 33(3):2220-2. PubMed ID: 11377507
    [No Abstract] [Full Text] [Related]

  • 25. Daclizumab to prevent rejection after cardiac transplantation.
    Hershberger RE, Starling RC, Eisen HJ, Bergh CH, Kormos RL, Love RB, Van Bakel A, Gordon RD, Popat R, Cockey L, Mamelok RD.
    N Engl J Med; 2005 Jun 30; 352(26):2705-13. PubMed ID: 15987919
    [Abstract] [Full Text] [Related]

  • 26. Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression.
    Ciancio G, Miller A, Burke GW, Gharagozloo H, Rosen A, Roth D, Kupin W, Pinna A, Cespedes M, Esquenazi V, Miller J.
    Transplant Proc; 2001 Jun 30; 33(1-2):1013-4. PubMed ID: 11267169
    [No Abstract] [Full Text] [Related]

  • 27. The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients.
    Eckhoff DE, McGuire B, Sellers M, Contreras J, Frenette L, Young C, Hudson S, Bynon JS.
    Transplantation; 2000 May 15; 69(9):1867-72. PubMed ID: 10830224
    [Abstract] [Full Text] [Related]

  • 28. The role of newer monoclonal antibodies in renal transplantation.
    Vincenti F.
    Transplant Proc; 2001 May 15; 33(1-2):1000-1. PubMed ID: 11267163
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal transplantation: a prospective, randomized study.
    Kandus A, Arnol M, Omahen K, Oblak M, Vidan-Jeras B, Kmetec A, Bren AF.
    Transplantation; 2010 Apr 27; 89(8):1022-7. PubMed ID: 20075788
    [Abstract] [Full Text] [Related]

  • 33. Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation.
    Platz KP, Mueller AR, Willimski C, Mansoorian B, Berg T, Neuhaus R, Hopf U, Lobeck H, Neuhaus P.
    Transplant Proc; 1998 Jun 27; 30(4):1468-9. PubMed ID: 9636596
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Liver transplant induction trial of daclizumab to spare calcineurin inhibition.
    Heffron TG, Smallwood GA, Pillen T, Davis L, Martinez E, Romero R, Stieber AC.
    Transplant Proc; 2002 Aug 27; 34(5):1514-5. PubMed ID: 12176462
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Anti-interleukin 2-receptor antibodies: a comparative study with polyclonal antibodies in kidney transplantation: preliminary results.
    Martins L, Henriques AC, Dias L, Sarmento AM, Pereira MC, Guimarães S.
    Transplant Proc; 2000 Dec 27; 32(8):2623-5. PubMed ID: 11134730
    [No Abstract] [Full Text] [Related]

  • 40. Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
    Bruce DS, Sollinger HW, Humar A, Sutherland DE, Light JA, Kaufman DB, Alloway RR, Lo A, Stratta RJ.
    Transplantation; 2001 Nov 27; 72(10):1637-43. PubMed ID: 11726823
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.